Vascular stents are small tubular scaffolds widely used in the treatment of arterial stenosis (narrowing of the vessel) to prevent acute vessel closure and late restenosis in a variety of vessels such as coronary arteries. According to Gen Consulting Company, global vascular stent market is expected to reach USD 10,984.67 million by the end of 2026, expanding at a CAGR of 6.68% over the forecast period i.e. 20202026. Increasing number of angioplasty procedures, rising burden of vascular diseases and the rising geriatric population are the major factors driving the growth of the market.

The vascular stent market is segmented on the basis of product, type, application, and region. The report offers a breakdown of market shares by product, including Coronary Stents, Peripheral Vascular Stents, Carotid Artery Stents, Renal Artery Stents. Based on type, the market for vascular stent is segmented into Bare Metal Stents (BMS), Bioabsorbable Stents (BAS), Covered Stents, Drug Eluting Stents (DES). By application, the vascular stent market is classified into Hospitals, Ambulatory Surgery Centers (ASCs). On the basis of region, the vascular stent industry is analyzed across North America, Europe, AsiaPacific, South America and MEA (the Middle East, and Africa).

By Product:
Coronary Stents
Peripheral Vascular Stents
Carotid Artery Stents
Renal Artery Stents

By Type:
Bare Metal Stents (BMS)
Bioabsorbable Stents (BAS)
Covered Stents
Drug Eluting Stents (DES)

By Application:
Hospitals
Ambulatory Surgery Centers (ASCs)

By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2020 to 2026.
North America (U.S., Canada, Mexico, etc.)
AsiaPacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)

The market research report covers the analysis of key stake holders of the vascular stent market. Some of the leading players profiled in the report include:
Abbott Laboratories
B. Braun Melsungen AG
Becton, Dickinson and Company
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Group Incorporated
Getinge AB
Kyoto Medical Planning Co., Ltd.
Lepu Medical Technology (Beijing) Co., Ltd.
Medtronic plc
MicroPort Scientific Corporation
Sahajanand Medical Technologies Pvt. Ltd.
Terumo Corporation
W. L. Gore & Associates, Inc.
*list is not exhaustive, request free sample to get a complete list of companies

The base year of the study is 2019, and forecasts run up to 2026.

Research Objective
To analyze and forecast the market size of global vascular stent market.
To classify and forecast global vascular stent market based on product, type, application, and region.
To identify drivers and challenges for global vascular stent market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global vascular stent market.
To conduct pricing analysis for global vascular stent market.
To identify and analyze the profile of leading players operating in global vascular stent market.

The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are:
Manufacturers of vascular stent
Raw material suppliers
Market research and consulting firms
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to vascular stent